- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Sunitinib malate – March 2012
Sunitinib malate, capsule, 12.5 mg, 25 mg and 50 mg (base), Sutent®
Last updated
8 November 2023